Terms: = Lung cancer AND PIK3R1, P27986, 5295, ENSG00000145675, p85-ALPHA, GRB1
27 results:
1. Identification of multiple organ metastasis-associated hub mRNA/miRNA signatures in non-small cell lung cancer.
Zu L; He J; Zhou N; Tang Q; Liang M; Xu S
Cell Death Dis; 2023 Dec; 14(12):798. PubMed ID: 38057344
[TBL] [Abstract] [Full Text] [Related]
2. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Taxus chinensis against non-small cell lung cancer.
Zhang S; Wang J; Zhang H
Medicine (Baltimore); 2023 Nov; 102(44):e35826. PubMed ID: 37933017
[TBL] [Abstract] [Full Text] [Related]
3. Development of the prognostic value in lung adenocarcinoma based on anoikis-related genes and initial experimental validation.
Guo W; Zhao G; Liu S; Deng T; Zhang G; Zhang B
J Gene Med; 2023 Sep; 25(9):e3534. PubMed ID: 37259225
[TBL] [Abstract] [Full Text] [Related]
4. Determining the mechanism of action of the Qishan formula against lung adenocarcinoma by integration of network pharmacology, molecular docking, and proteomics.
Geng X; Chi W; Lin X; Niu Z; Jiang Q; Sui Y; Jiang J
Medicine (Baltimore); 2023 Mar; 102(13):e33384. PubMed ID: 37000102
[TBL] [Abstract] [Full Text] [Related]
5. Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell lung cancer by Integrated Bioinformatics Analysis.
Yu L; Liang X; Wang J; Ding G; Tang J; Xue J; He X; Ge J; Jin X; Yang Z; Li X; Yao H; Yin H; Liu W; Yin S; Sun B; Sheng J
Genet Res (Camb); 2023; 2023():6782732. PubMed ID: 36688087
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Value Screening, Prognostic Significance, and Key Gene Identification of TrkB in Laryngeal Carcinoma.
Zhang J; Hu X; Liu S; He Y; Lyu L; Jiang L
Dis Markers; 2022; 2022():1354005. PubMed ID: 36033826
[TBL] [Abstract] [Full Text] [Related]
7. Bioinformatics Analysis Screened and Identified Key Genes as Potential Biomarkers for Progression of lung cancer.
Chen Y; Wang XK; Wang Y; Zong JW; Wang SY; Wan XY
J Coll Physicians Surg Pak; 2022 Jun; 32(6):712-721. PubMed ID: 35686401
[TBL] [Abstract] [Full Text] [Related]
8. Molecular Genetic Landscape of Sclerosing Pneumocytomas.
Boland JM; Lee HE; Barr Fritcher EG; Voss JS; Jessen E; Davila JI; Kipp BR; Graham RP; Maleszewski JJ; Yi ES
Am J Clin Pathol; 2021 Feb; 155(3):397-404. PubMed ID: 33145590
[TBL] [Abstract] [Full Text] [Related]
9. Integration of gene profile to explore the hub genes of lung adenocarcinoma: A quasi-experimental study.
Hua P; Zhang Y; Jin C; Zhang G; Wang B
Medicine (Baltimore); 2020 Oct; 99(43):e22727. PubMed ID: 33120770
[TBL] [Abstract] [Full Text] [Related]
10. The Small GTPase ARF6 Activates PI3K in Melanoma to Induce a Prometastatic State.
Yoo JH; Brady SW; Acosta-Alvarez L; Rogers A; Peng J; Sorensen LK; Wolff RK; Mleynek T; Shin D; Rich CP; Kircher DA; Bild A; Odelberg SJ; Li DY; Holmen SL; Grossmann AH
Cancer Res; 2019 Jun; 79(11):2892-2908. PubMed ID: 31048499
[TBL] [Abstract] [Full Text] [Related]
11. Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression.
Jin H; Jang Y; Cheng N; Li Q; Cui PF; Zhou ZW; Jiang HL; Cho MH; Westover KD; Tan QY; Xu CX
J Exp Clin Cancer Res; 2019 Apr; 38(1):165. PubMed ID: 30987652
[TBL] [Abstract] [Full Text] [Related]
12. Expression of miR-486-5p and its significance in lung squamous cell carcinoma.
Yang S; Sui J; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
J Cell Biochem; 2019 Aug; 120(8):13912-13923. PubMed ID: 30963622
[TBL] [Abstract] [Full Text] [Related]
13. Trans-3,5,4´-trimethoxystilbene reduced gefitinib resistance in NSCLCs via suppressing MAPK/Akt/Bcl-2 pathway by upregulation of miR-345 and miR-498.
Lu M; Liu B; Xiong H; Wu F; Hu C; Liu P
J Cell Mol Med; 2019 Apr; 23(4):2431-2441. PubMed ID: 30701693
[TBL] [Abstract] [Full Text] [Related]
14. miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer.
Gao ZJ; Yuan WD; Yuan JQ; Yuan K; Wang Y
Pathol Res Pract; 2018 May; 214(5):700-705. PubMed ID: 29567332
[TBL] [Abstract] [Full Text] [Related]
15. RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1.
Chen SH; Gong X; Zhang Y; Van Horn RD; Yin T; Huber L; Burke TF; Manro J; Iversen PW; Wu W; Bhagwat SV; Beckmann RP; Tiu RV; Buchanan SG; Peng SB
Oncogene; 2018 Feb; 37(6):821-832. PubMed ID: 29059158
[TBL] [Abstract] [Full Text] [Related]
16. MicroRNA-Related Polymorphisms in PI3K/Akt/mTOR Pathway Genes Are Predictive of Limited-Disease Small Cell lung cancer Treatment Outcomes.
Jiang W; Zhang W; Wu L; Liu L; Men Y; Wang J; Liang J; Hui Z; Zhou Z; Bi N; Wang L
Biomed Res Int; 2017; 2017():6501385. PubMed ID: 28280736
[TBL] [Abstract] [Full Text] [Related]
17. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
[TBL] [Abstract] [Full Text] [Related]
18. MicroRNA-related polymorphisms in apoptosis pathway genes are predictive of clinical outcome in patients with limited disease small cell lung cancer.
Jiang W; Bi N; Zhang WJ; Wu LH; Liu LP; Men Y; Wang JB; Liang J; Hui ZG; Zhou ZM; Wang LH
Oncotarget; 2016 Apr; 7(16):22632-8. PubMed ID: 26988918
[TBL] [Abstract] [Full Text] [Related]
19. Gene expression profiling of lung adenocarcinoma in Xuanwei, China.
Wu H; Meng S; Xu Q; Wang X; Wang J; Gong R; Song Y; Duan Y; Zhang Y
Eur J Cancer Prev; 2016 Nov; 25(6):508-17. PubMed ID: 26695082
[TBL] [Abstract] [Full Text] [Related]
20. Identification of carcinogenic potential-associated molecular mechanisms in CD133(+) A549 cells based on microRNA profiles.
Chen QY; Jiao DM; Zhu Y; Hu H; Wang J; Tang X; Chen J; Yan L
Tumour Biol; 2016 Jan; 37(1):521-30. PubMed ID: 26227219
[TBL] [Abstract] [Full Text] [Related]
[Next]
